Subsequently, a further group of mutations in negative regulators of the nuclear factor κB (NF-κB) signaling was observed in 7 to 41% of cases, suggesting that NF-κB activation is selected for during NPC pathogenesis (12, 13). The gene discussed is NFKB1; the disease is nasopharyngeal carcinoma.